Invivyd (IVVD) Non-Current Deferred Tax Liability (2023 - 2025)
Invivyd (IVVD) posted Non-Current Deferred Tax Liability of $719000.0 for Q4 2025, down 99.22% on a QoQ basis from $92.0 million in Q4 2024, and down 99.22% year-over-year from $92.0 million in Q4 2024.
Invivyd (IVVD) Non-Current Deferred Tax Liability (2023 - 2025) Analysis & Trends
Invivyd's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $719000.0 for Q4 2025.
- Quarterly Non-Current Deferred Tax Liability fell 99.22% year-over-year to $719000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (down 99.22% YoY) and the FY2025 annual result came in at $719000.0, down 99.22% from the prior year.
- Non-Current Deferred Tax Liability was $719000.0 for Q4 2025 at Invivyd, down from $92.0 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $92.0 million in Q4 2024 and bottomed at $719000.0 in Q4 2025.
- A 3-year average of $55.6 million and a median of $74.1 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability grew 24.07% — and 2025, when it plunged 99.22%.
- Invivyd's Non-Current Deferred Tax Liability stood at $74.1 million in 2023, then increased by 24.07% to $92.0 million in 2024, then plunged by 99.22% to $719000.0 in 2025.
- Business Quant data shows IVVD's Non-Current Deferred Tax Liability at $719000.0 in Q4 2025, $92.0 million in Q4 2024, and $74.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2025 | 719,000.00 |
| Dec 31, 2024 | 91.95 Mn |
| Dec 31, 2024 | 91.95 Mn |
| Dec 31, 2023 | 74.12 Mn |
| Dec 31, 2023 | 74.12 Mn |